User profiles for Chrysta C. Lienczewski

Chrysta Lienczewski

Clinical Research Project Manager
Verified email at umich.edu
Cited by 1138

[HTML][HTML] Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach

…, JB Kopp, KV Lemley, PJ Nelson, CC Lienczewski… - Kidney international, 2013 - Elsevier
The Nephrotic Syndrome Study Network (NEPTUNE) is a North American multicenter
collaborative consortium established to develop a translational research infrastructure for …

[HTML][HTML] SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease

…, JA Schaub, CC Berthier, S Eddy, CC Lienczewski… - Kidney international, 2020 - Elsevier
COVID-19 morbidity and mortality are increased in patients with diabetes and kidney
disease via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) …

[HTML][HTML] Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today

…, C Gadegbeku, L Subramanian, CC Lienczewski… - Kidney international, 2024 - Elsevier
Glomerular diseases are classified using a descriptive taxonomy that is not reflective of the
heterogeneous underlying molecular drivers. This limits not only diagnostic and therapeutic …

[HTML][HTML] Strategy and rationale for urine collection protocols employed in the NEPTUNE study

MC Hogan, JC Lieske, CC Lienczewski, LL Nesbitt… - BMC nephrology, 2015 - Springer
Background Glomerular diseases are potentially fatal, requiring aggressive interventions and
close monitoring. Urine is a readily-accessible body fluid enriched in molecular signatures …

SARS-CoV-2 receptor networks in diabetic kidney disease, BK-Virus nephropathy and COVID-19 associated acute kidney injury

…, JA Schaub, CC Berthier, S Eddy, CC Lienczewski… - 2020 - pesquisa.bvsalud.org
COVID-19 morbidity and mortality is increased in patients with diabetes and kidney disease
via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) for …

SARS-CoV-2 Receptor Networks in Diabetic Kidney Disease, BK Virus Nephropathy, and COVID-19 Associated AKI: SA-OR04

…, CC Berthier, S Eddy, CC Lienczewski… - Journal of the …, 2020 - journals.lww.com
Background: COVID-19 shows increased disease burden in patients with diabetic kidney
disease (DKD). SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) for host cell entry, …

[HTML][HTML] Assessment of the Needs of Nephrology Divisions to Implement Return of Clinically Significant Research Genetic Results: A Survey of Nephrotic Syndrome …

JE Fishbein, L Wilson Dass, C Lienczewski… - Glomerular …, 2023 - karger.com
Introduction: There is an increasing need to return genetic testing results to patients with
kidney disease who were first genotyped on a research basis. Operationalizing this process in …

[PDF][PDF] An eQTL landscape of kidney tissue in human nephrotic syndrome

…, J Zee, E Herreshoff, C Kincaid, C Lienczewski… - The American Journal of …, 2018 - cell.com
Expression quantitative trait loci (eQTL) studies illuminate the genetics of gene expression
and, in disease research, can be particularly illuminating when using the tissues directly …

Urine podocyte mRNAs mark progression of renal disease

…, JW Chang, JE Wiggins, C Lienczewski… - Journal of the …, 2009 - journals.lww.com
Because loss of podocytes associates with glomerulosclerosis, monitoring podocyte loss by
measuring podocyte products in urine may be clinically useful. To determine whether a …

Rationale and design of the kidney precision medicine project

…, K Kiryluk, R Knight, ZG Laszik, C Lienczewski… - Kidney international, 2021 - Elsevier
Chronic kidney disease (CKD) and acute kidney injury (AKI) are common, heterogeneous,
and morbid diseases. Mechanistic characterization of CKD and AKI in patients may facilitate a …